About MycoDART
MycoDART is a company based in Carrollton (United States) founded in 2018.. MycoDART has raised $30 thousand across 1 funding round. MycoDART offers products and services including Candida Diagnostic Panel, Aspergillus Diagnostic Panel, and Mucor Diagnostic Panel. MycoDART operates in a competitive market with competitors including Inflammatix, Visby Medical, MeMed, GenMark Diagnostics and Molbio Diagnostics, among others.
- Headquarter Carrollton, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Mycodart, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$30 K (USD)
in 1 rounds
-
Latest Funding Round
$30 K (USD), Seed
Dec 18, 2018
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MycoDART
MycoDART offers a comprehensive portfolio of products and services, including Candida Diagnostic Panel, Aspergillus Diagnostic Panel, and Mucor Diagnostic Panel. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Qualitative PCR test for detecting Candida species in blood samples.
Qualitative PCR test for detecting Aspergillus species in patient samples.
Qualitative PCR test for detecting Mucor species in biological samples.
Funding Insights of MycoDART
MycoDART has successfully raised a total of $30K through 1 strategic funding round. The most recent funding activity was a Seed round of $30 thousand completed in December 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $30,000
-
First Round
First Round
(18 Dec 2018)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2018 | Amount | Seed - MycoDART | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by MycoDART
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - MycoDART
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Mycodart Comparisons
Competitors of MycoDART
MycoDART operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Visby Medical, MeMed, GenMark Diagnostics and Molbio Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of diagnostic solutions for systemic infections
|
|
| domain | founded_year | HQ Location |
Portable PCR diagnostics for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| domain | founded_year | HQ Location |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| domain | founded_year | HQ Location |
Point-of-care molecular platforms for infectious disease detection are developed.
|
|
| domain | founded_year | HQ Location |
Diagnostic technologies for infectious, cancer, and neurological diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Mycodart
Frequently Asked Questions about MycoDART
When was MycoDART founded?
MycoDART was founded in 2018.
Where is MycoDART located?
MycoDART is headquartered in Carrollton, United States. It is registered at Carrollton, Texas, United States.
Is MycoDART a funded company?
MycoDART is a funded company, having raised a total of $30K across 1 funding round to date. The company's 1st funding round was a Seed of $30K, raised on Dec 18, 2018.
What does MycoDART do?
MycoDART was established in 2018 in Carrollton, United States, within the healthcare diagnostics sector. Operations center on molecular testing for infectious pathogens. A proprietary platform employing quantitative PCR for DNA probe analysis is used. This technology supports detection of conditions including sepsis, Candida species, and fungal infections such as Aspergillus and Mucor. Additional applications for various diseases are included in the service offerings.
Who are the top competitors of MycoDART?
MycoDART's top competitors include Visby Medical, Inflammatix and MeMed.
What products or services does MycoDART offer?
MycoDART offers Candida Diagnostic Panel, Aspergillus Diagnostic Panel, and Mucor Diagnostic Panel.